Patent ID: 7115373

Claim:
A method of testing for the remission stage of atopic dermatitis that is associated with a decrease in eosinophil cell number in a test subject having atopic dermatitis, said method comprising the steps of: (a) measuring the expression level of the NOR-1 gene in the eosinophil cells of the test subject having atopic dermatitis; and (b) comparing the expression level measured with the expression level of the NOR-1 gene in the eosinophil cells of the test subject during the exacerbation stage of atopic dermatitis, wherein the remission stage of atopic dermatitis that is associated with a decrease in eosinophil cell number is indicated by an increase in the level of NOR-1 gene expression in the eosinophil cells of the test subject having atopic dermatitis as compared with that in the eosinophil cells of the test subject during the exacerbation stage of atopic dermatitis.